Proteomics analyses could present opportunities to diagnose dementias

STOCKHOLM: One of the most intriguing properties of the brain is its means to undergo… read more

Pfizer finally abandons dementia drug trials

LONDON: Pharmaceutical giant Pfizer says it will stop looking for new Alzheimer’s drugs, implicitly accepting… read more

Seniors playgrounds set to be built here

CANBERRA: They might not be kids anymore, but that does not mean seniors are too… read more

Bad week for dementia R&D after Axovant howler & another failed trial

BERNE: A bad week for dementia research just got worse after Axovant embarrassingly admitted it… read more